EDN1 and pulmonary arterial hypertension: Endothelin-1 (ET-1) is a promising biomarker for predicting BPD, as it is associated with bronchoconstriction and pulmonary hypertension, with elevated levels indicating early risk in preterm infants with nRDS (3–5).